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Objective: We evaluated, in the prevention of perioperative unintentional 
myocardial ischemia, the role of coronary collateral flow in patients with 
left anterior descending coronary artery stenosis or occlusion who under- 
went elective coronary artery bypass grafting. Methods: Coronary lesions 
and collaterals were assessed by coronary angiography in 21 patients. 
Anteroseptal myocardial viability was evaluated by dobutamine chocardi- 
ography. Antegrade perfusion f cardioplegic solution was assessed by 
myocardial contrast echocardiography. Time-intensity curves were gener- 
ated from the anteroseptal region. Twelve parameters were measured and 
averaged in the following four groups of patients: those with stenosis of the 
left anterior descending artery and poor collaterals; those with stenosis of 
the left anterior descending artery and good collaterals; those with occlu- 
sion of the left anterior descending artery and good collaterals; and those 
with occlusion of the left anterior descending artery and poor collaterals. 
Results: Time-intensity curves were significantly different in patients with 
stenosis versus occlusion of the left anterior descending artery (p < 0.005); 
multiple comparisons with Bonferroni's correction showed that this differ- 
ence was mainly a result of the impact of collateral circulation (p < 0.01). 
However, the role of collaterals was nonsignificant within the groups with 
stenosis and occlusion of the left anterior descending artery. Patients with 
occlusion of the left anterior descending artery and good collaterals had 
perfusion parameters similar to those of patients with stenosis of the left 
anterior descending artery (p = not significant), except for the ascending 
slope and time to peak values (p < 0.05 and p < 0.01, respectively), which 
reflected a higher flow resistance in the collateral circulation. Regional 
systolic function after coronary artery bypass grafting was depressed in 
patients with poor collaterals and poor perfusion of cardioplegic solution, 
as compared with findings in other subgroups. Conclusions: Incomplete myo- 
cardial protection may impair the early recovery of function after coronary 
artery bypass grafting. (J Thorac Cardiovasc Surg 1997;113:585-93) 
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T he role of coronary collateral circulation in pre- serving regional myocardial perfusion has been 
demonstrated by coronary angiography, 1'2 by nu- 
clear methods, 3 and, more recently, by myocardial 
contrast echocardiography (MCE). 4-s Coronary an- 
giography detects vessels of greater than 100/xm in
diameter and might underestimate collateral flow in 
patients with poor collateral circulation] Preopera- 
tive perfusion imaging techniques may not predict 
the intraoperative perfusion pattern, because during 
delivery of cardioplegic solution (1) the flow pattern 
may be different from that of the beating heart, (2) 
there is maximal vasodilation of the microcircula- 
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Table I. Clinical and coronary angiographic 
findings 
LAD stenosis LAD occlusion 
Good Poor Good Poor 
collaterals collaterals collaterals" collaterals 
No. of patients 4 8 5 4 
Age in years 54.8 ± 4.3 58.9 ± 8.3 55.8 -+ 7.5 60.5 ± 8.7 
(mean ± SD) 
Sex 
Male 4 7 5 3 
Female 0 1 0 1 
Previous anterior MI 
Yes 1 1 1 1 
No 3 7 4 3 
Hypertension 
Yes 1 3 3 4 
No 3 5 2 0 
Diabetes 
Yes 1 2 1 1 
No 3 6 4 3 
Regional LV function 
Normal (->50%) 3 5 3 0 
Impaired 0 2 1 3 
(49%-20%) 
Severely impaired 1 1 1 1 
(<20%) 
SD, Standard eviation; MI, myocardial infarction; LV, left ventricular. 
tion, including collateral vessels, and (3) perfusate- 
induced endothelial damage may occur. 9' 10 
MCE may provide information on myocardial per- 
fusion in the beating or arrested heart 4'8' 11-17 and 
may be used to study distribution of cardioplegic 
solution during coronary artery bypass grafting 
(GANG) .8 '  12,14,15 In  patients with  coronary  occlusion, 
nonhomogeneous di tribution of cardioplegic solution 
delivered in an antegrade manner may cause "unin- 
tentional myocardial ischemia," which may lead to 
myocardial stunning or necrosis. 18-2° In this clinical 
setting, the role of collateral circulation is critical, and 
the identification of inadequate myocardial perfusion 
may help the surgeon plan combined antegrade/retro- 
grade cardioplegia procedures. 4' s, 2o 
The aim of the present study was to evaluate by 
intraoperative MCE the protective role of coronary 
collateral flow on preserving myocardial perfusion 
and function in patients with symptomatic chronic 
coronary artery disease and proximal left anterior 
descending artery (LAD) stenosis or occlusion who 
underwent elective coronary operation. 
Methods 
Patient selection. Twenty-one patients undergoing 
elective CABG because of symptomatic chronic coronary 
Table II. Parameters o f  the videointensity curves 
LAD stenosis LAD occlusion 
Parameters (n* = 12) (n = 9) 
Videointensity units 
Peak height 47.5 + 14.5 22.0 ± 12.3 
Area at 1 sec 16.2 ± 9.0 4.1 ± 2.2 
Area at 2 sec 54.7 ± 22.9 15.1 + 7.7 
Area at 3 sec 98.1 ± 33.5 30.6 _+ 16.0 
Area at 4 sec 136.0 + 40.1 49.4 + 26.5 
Area at 5 sec 164.4 ± 44.5 70.2 ± 38.0 
Area at 6 sec 185.3 _+ 50.7 90.4 _+ 49.7 
Area at 7 sec 200.9 _+ 56.5 106.1 _+ 59.9 
Area at peak 64.5 _+ 25.9 68.0 _+ 42.6 
Videointensity units/sec 
Ascending slope 23.4 _+ 10.5 4.4 _+ 2.6 
Descending slope -7.7 _+ 3.4 -4.3 _+ 2.8 
Time (sec) 
Time to peak 2.3 _+ 0.6 4.8 _+ 0.6 
Values are expressed as mean plus or minus standard eviation. 
*Number of patients. 
artery disease and proximal esions of the LAD were 
enrolled in this study. Approval of the study protocol by 
the institution's Ethics Committee on Clinical Investiga- 
tions and informed consent from each patient were ob- 
tained. Coronary artery lesions were considered signifi- 
cant when cross-sectional area loss was 75% or greater; 
arteries were considered occluded when cross-sectional 
area loss was 100%. 
Coronary collateral circulation was classified into two 
categories (good and poor) on the basis of the degree 
of opacification of the epicardial segment of the recip- 
ient artery on the coronary angiograms. 2 In patients 
with good collateral circulation, both collaterals and 
epicardial arteries distal to an occlusion or stenosis 
were well visualized. Conversely, in patients with poor 
collateral circulation, the visualization of collaterals 
and epicardial arteries distal to an occlusion or stenosis 
was faint. Patients with aortic incompetence or left 
ventricular aneurysm were excluded from the study. 
Wall motion was observed in the biplanar left ventricu- 
logram in all patients. Left anteroseptal wall motion 
was graded on the basis of angiographically determined 
regional ejection fraction into normal (->50%), im- 
paired (49% to 20%), and severely impaired (<20%). 
Clinical and coronary angiographic findings are shown 
in Table I. 
Anesthetic technique. Anesthesia was induced with 
fentanyl (30 to 35 /xg/kg), diazepam (0.25 to 0.5 mg/kg), 
and succinylcholine (1.5 mg/kg) and was maintained with 
fentanyl, droperidol, pancuronium bromide, and a 50% 
N20 and oxygen mixture. 
Surgical technique. CABG was done during cardiopul- 
monary bypass. Systemic hypothermia (25 ° to 28 ° C) was 
maintained throughout the procedure. A total of 79 grafts 
(average 3.8 _+ 1.2 grafts per patient) were placed: 58 were 
of inverted saphenous vein and 21 of internal thoracic 
artery. The internal thoracic arteries were always grafted 
to the LAD. 
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Fig. 1. Cumulative time-intensity curves from images obtained in the four subgroups of patients. Group 1, 
Patients with LAD stenosis and poor collaterals; group 2, patients with LAD stenosis and good collaterals; 
group 3, patients with LAD occlusion and good collaterals; group 4, patients with LAD occlusion and poor 
collaterals. 
Cardioplegia techniques. Myocardial protection was 
achieved by inducing topical hypothermia with iced saline 
slush and by administration of cold (4 ° C) potassium 
crystalloid cardioplegic solution (30 mEq/L of potassium 
chloride in the first dose and 15 mEq/L in all the 
subsequent doses). Cardioplegic solution was infused in 
an antegrade manner via the aortic root at a pressure of 70 
to 80 mm Hg. An initial volume of cardioplegic solution 
(10 ml/kg) was infused over 2 minutes through the aortic 
root. Left ventricular venting was done through the left 
atrium. Administration of cardioplegic solution was re- 
peated every 20 minutes throughout the ischemic period 
with a 15 mEq/L potassium concentration. 
Assessment of myocardial viability. All patients under- 
went preoperative (transthoracic) and intraoperative 
(transesophageal) dobutamine chocardiographic testing 
at a dose of 5 /xg/kg per minute to study myocardial 
viability in the anteroseptal wall. Preoperative assessment 
was done in the standard parasternal nd apical views, and 
the anteroseptal wall was assigned one of the following 
wall motion scores: -1,  hyperkinetic; 0, normal; 1, hypo- 
kinetic; 2, akinetic; and 3, dyskinetic. The intraoperative 
assessment was done by single-plane transesophageal 
echocardiography, with use of a previously reported meth- 
odY Myocardial wall thickness was measured uring the 
same cardiac cycle at end systole (SWT) and at end 
diastole (DWT)Y Percent systolic wall thickening 
(PSWT) of the anteroseptal wall was calculated according 
to the formula 
SWT - DWT 
PSWT-  × 100 DWT 
Serial 12-lead electrocardiograms and cardiac enzyme 
measurements (creatine kinase MB) were done to exclude 
the occurrence of perioperative myocardial infarction. 
Echocardiographic contrast agent. The echocardio- 
graphic contrast agent was prepared under sterile condi- 
tions 1 hour before the operation with use of a standard- 
ized protocol developed at the University of Rome, "La 
Sapienza, ''22 and based on guidelines for albumin sonica- 
tion developed at the University of ChicagoY 
Perfusion imaging technique. Aortic incompetence, 
which may cause inadequate myocardial perfusion during 
antegrade cardioplegia, I5 was ruled out before bypass by 
transesophageal echocardiographic color Doppler imag- 
ing. 
The echocardiographic contrast agent was injected soon 
after hypothermic arrest through a side branch of the 
cardioplegia conduit. Two contrast injections of 2 ml were 
scheduled for each patient during antegrade cardioplegia. 
The first injection was done during imaging of the aortic 
valve and the left ventricle to rule out unexpected aortic 
regurgitation during aortic crossclamping15; the second 
injection was done during imaging of the left ventricle in 
the short-axis view at the level of the papillary muscle to 
evaluate myocardial perfusion. 
Contrast echocardiographic analysis. Contrast echo- 
cardiograms were recorded on SVHS magnetic tape and 
digitized off-line with use of a 151 Imaging Technology 
image processor connected with an IBM PS-2 80 com- 
puter and displayed on a 512 by 512 pixel screen with 256 
gray level scale or intensity units per pixel. One region of 
interest of at least 100 pixels was drawn in the midantero- 
septal wall of the left ventricular myocardium, excluding 
endocardial and epicardial borders. Quantitative mea- 
surements were made by continuous, automatic acquisi- 
tion at a rate of 15 frames/sec, starting before contrast 
appearance and continuing for 7 seconds. Background- 
subtracted time-intensity curves were generated and aver- 
aged in four patient groups: those with LAD stenosis and 
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Tab le  I I I .  Results o f  univariate analysis o f  variance 
Parameters 
p Values 
LAD stenosis LAD occlusion Main effect, Main effect, 
(n = 12) * (n = 9) ? LAD disease collaterals interactions 
Videointensity units 
Peak height 0.0003 0.5439 0.0157 
Good collaterals 40.0 ± 7.8 30.0 ± 10.8 
Poor collaterals 51.3 _+ 15.9 12.0 ± 2.4 
Area at peak 0.9234 0.0662 0.0271 
Good collaterals 60.5 ± 11.8 93.7 ± 41.6 
Poor collaterals 66.5 ± 31.4 35.9 ± 7.0 
Area at 1 see 0.0018 0.2928 0.0795 
Good collaterals 10.4 ± 5.8 5.1 _+ 2.5 
Poor collaterals 19.1 ± 9.1 2.8 ± 0.7 
Area at 2 see 0.0001 0.3630 0.0342 
Good collaterals 38.8 ± 15.6 19.6 _+ 7.8 
Poor collaterals 62.7 ± 22.4 9.4 _+ 1.7 
Area at 3 sec <0.0001 0.6667 0.0231 
Good collaterals 76.2 ± 21.4 40.9 ± 14,5 
Poor collaterals 109.0 ± 34.0 17.8 ± 2.2 
Area at 4 see <0.0001 0.8676 0.0198 
Good collaterals 113.2 _+ 25.5 66.8 _+ 23.5 
Poor collaterals 147.5 ± 42.5 27.7 ± 2.5 
Area at 5 sec <0.0001 0.4547 0.0208 
Good collaterals 144.1 ± 29.1 95.3 - 33.5 
Poor collaterals 174.5 ± 49.0 38.9 ± 3.7 
Area at 6 see 0.0002 0.2736 0.0237 
Good collaterals 166.9 ± 31.3 123.0 ± 43.8 
Poor collaterals 194.4 ± 57.7 49.6 ± 5.8 
Area at 7 see 0.0007 0.1886 0.0270 
Good collaterals 184.6 ± 32.2 145.4 _+ 52.8 
Poor collaterals 209.0 ± 65.9 57.1 ± 7.6 
Videointensity units/sec 
Ascending slope 
Good collaterals 16.2 ± 5.8 
Poor collaterals 26.9 -+ 10.8 
Descending slope 
Good collaterals -6.1 _+ 1.7 
Poor collaterals -8.5 + 3.9 
Time to peak 
Good collaterals 2.6 _+ 0.5 
Poor collaterals 2.1 _+ 0.6 
6.1 ± 2.2 
2.2 ± 0.7 
-5.7 ± 3.3 
2.7 ± 0.5 
Time (sec) 
4.8 + 0.8 
4.8 ± 0.5 
0.0001 0.3279 0.0445 
0.0380 0.8255 0.0669 
<0.0001 0.2891 0.3727 
Values are expressed asmean plus or minus tandard deviation. 
*Four patients with good collaterals, 8 patients with poor collaterals. 
tFive patients with good collaterals, 4 patients with poor collaterals. 
:~Interaction refers to comparisons among patients with LAD disease (stenosis versus occlusion) and good or poor collaterals. 
poor collaterals; those with LAD stenosis and good col- 
laterals; those with LAD occlusion and good collaterals; 
and those with LAD occlusion and poor collaterals. For 
each curve the following parameters were calculated: time 
to peak, peak of the curve, area at peak, area under the 
curve at every 0.5 second up to 7 seconds, and slope of the 
regression lines fitted to the curve in two segments, 
ascending slope (from baseline to peak) and descending 
slope (from peak to the end of the curve). The ascending 
slope described contrast wash-in in the myocardium and 
the descending slope described contrast wash-out from 
the myocardium (see appendix). 
Statistical analysis. Categorical data were presented as 
absolute frequency. Quantitative measurements were ex- 
pressed as mean plus or minus the standard deviation. 
Clinical and angiographic findings were compared by 
analysis of variance (ANOVA) for quantitative variables 
and Fisher's exact probability test for categorical vari- 
ables. PSWT changes in the anteroseptal wall throughout 
the study were analyzed by paired Student's t test with 
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Table IV. Probability (p) values of the multiple comparisons with Bonferroni's correction 
Good vs poor collaterals LAD stenosis vs occlusion 
LAD stenosis LAD occlusion Good collaterals 
Parameters (n* = 12) (n = 9) (n = 9) 
Poor collaterals 
(n =12) 
Peak height NS <0.08 NS <0.003 
Area at peak NS NS NS NS 
Area at 1 sec NS NS NS <0.006 
Area at 2 sec NS NS NS <0.002 
Area at 3 sec NS <0.10 <0.09 <0.001 
Area at 4 sec NS <0.06 NS <0.001 
Area at 5 sec NS <0.06 NS <0.001 
Area at 6 sec NS <0.06 NS <0.001 
Area at 7 sec NS <0.08 NS <0.002 
Ascending slope NS <0.06 <0.04 <0.002 
Descending slope NS NS NS <0.02 
Time to peak NS NS <0.01 <0.001 
p Values reported are expressed according to the following approximation, e.g: p < 0.08 ~ 0.07 < p < 0.08; NS, Not significant. 
*Number of patients. 
Bonferroni's correction. PSWT paired values were com- 
pared at two steps: baseline versus dobutamine infusion 
and baseline versus after surgical revascularization. The 
parameters obtained from the time-intensity curves were 
analyzed by univariate ANOVA with LAD stenosis versus 
occlusion and good versus poor collateral circulation as 
between-subject factors. In particular, the ANOVA model 
included main effects of LAD disease and collateral 
circulation and their interaction. Multiple comparisons 
were done by applying the appropriate  test with Bonfer- 
roni's correction. A p value of -<0.05 was considered 
statistically significant; p values between 0.10 and 0.05 are 
also reported in the tables and text. Statistical analysis was 
done with BMDP/Dynamic software, release 7.0. 24 
Results 
Clinical variables among the four patient groups 
were not statistically different (Table I). 
Preoperative assessment of myocardial viability. 
Preoperative dobutamine transthoracic echocardiog- 
raphy showed viable myocardium in the anteroseptal 
wall in all patients (wall motion score index 0.7 _+ 0.8 
to -0.4 _+ 0.7; p < 0.0001), with clear indication for 
revascularization in all patients, including those with 
LAD occlusion and poor collaterals. 
Intraoperative perfusion imaging. Cumulative 
time-intensity curves generated from the opacifica- 
tion of the anteroseptal myocardium are shown in 
Fig. 1. Variable values of the curves are presented in 
Tables II and III. Univariate ANOVA showed that 
patients with LAD occlusion had a significant delay 
in time to peak, a significant lower peak height of 
the curve, and a lower area under the curve than 
patients with LAD stenosis (Table III). The contrast 
wash-in, measured by the ascending slope of the 
curve, and the contrast wash-out, measured by the 
descending slope of the curve, were significantly 
lower in patients with LAD occlusion versus respec- 
tive values in those with LAD stenosis alone. A 
significant interaction between LAD disease and 
collateral circulation was found with respect o all 
parameters, except for time to peak, area at 1 
second, and the descending slope (Table III). Mul- 
tiple comparison tests showed that the gap between 
LAD stenosis versus occlusion was mainly a result of 
the impact of poor collaterals for all the variables, 
but not the area at peak (Table IV). Conversely, in 
the presence of well-developed collateral circula- 
tion, a significant difference only persisted between 
patients with LAD stenosis and patients with LAD 
occlusion with respect to time to peak and ascending 
slope of the curve (Table IV). Furthermore, within 
the LAD stenosis and LAD occlusion groups, per- 
fusion parameters were not affected by the presence 
of good or poor collaterals (Table IV, Fig. 1). The 
lack of any significant difference in the area at peak 
among the patient groups was probably related to 
the different imes to peak in each group (Fig. 1, 
Tables III and IV). 
Figs. 2 and 3 are color-coded echocardiograms 
obtained during administration of contrast-en- 
hanced cardioplegic solution in two patients with 
LAD occlusion. Fig. 2 depicts findings in a patient 
without collateral circulation in whom a clear-cut 
perfusion defect was detected in the anteroseptal 
wall. Myocardial perfusion is best appreciated in the 
background-subtracted image (Fig. 2, lower panel), 
which shows the net effect of microbubble diffusion 
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Fig. 3. Intraoperative transesophageal chocardiography 
during antegrade administration of cardioplegic solution 
showing color-coded left ventricular short-axis view before 
(upper panel) and after (lower panel) contrast injection in 
a patient with occluded LAD and good collateral circula- 
tion. The lowerpanel shows good perfusion f the antero- 
septal wall. 
Fig. 2. Intraoperative transesophageal chocardiography 
during antegrade administration of cardioplegic solution 
showing color-coded left ventricular short-axis view before 
(upper panel) and during (middle and lower panels) con- 
trast injection in a patient with occluded LAD and poor 
collateral circulation. The alrow shows the perfusion defect 
in the anteroseptal wall. The lower panel is a digitally 
subtracted image from those in the middle and upper panels, 
showing residual perfusion in the subendocardium. 
through the myocardium with subendocardial pool- 
ing of the agent in the anteroseptal wall. Fig. 3 
depicts findings in a patient with good collateral 
circulation in whom the anteroseptal wall was well 
perfused. 
Intraoperative assessment of myocardial viabil- 
ity. Intraoperative dobutamine echocardiography 
testing confirmed myocardial viability in the antero- 
septal wall, with PSWT values increasing from 
12.6% +_ 8.2% at baseline to 25.9% _+ 13.9% during 
dobutamine infusion at 5 /xg/kg per minute (p < 
0.0001) in all patients and from 9.0% _+ 8.5% at 
baseline to 25.3% _+ 12.7% during dobutamine 
infusion (p < 0.05) in patients with LAD occlusion 
and poor collaterals (Table V, group 4). In this 
subgroup, antegrade distribution of cardioplegic so- 
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Table V. PSWT of the anteroseptal region at baseline, during dobutamine infusion, and after CABG in the 
four subgroups of patients with LAD disease 
PSWT (%) p Values 
Dobutamine After Baseline vs Baseline vs after 
Group No. of patients Baseline infusion CABG dobutamine CABG 
Group 1 8 13.4 _+ 9.6 28.8 _+ 18.5 32.4 _+ 14.1 <0.02 <0.002 
Group 2 4 10.3 _+ 6.3 20.3 _+ 9.3 21.8 _+ 7.4 <0.05 <0.02 
Group 3 5 16.2 _+ 7.1 26.4 _+ 11.7 38.6 _+ 17.5 <0.05 <0.03 
Group 4 4 9.0 _+ 8.5 25.3 _+ 12.7 16.3 _+ 7.4 <0.05 <0.08 
Al l  pat ients 21 12.6 _+ 8.2 25.9 _+ 13.9 28.8 _+ 14.8 <0.0001 <0.0001 
Values are expressed as mean plus or minus standard eviation. Group 1, LAD stenosis and poor collaterals; group 2, LAD stenosis and good collaterals; 
group 3, LAD occlusion and good collaterals; group 4, LAD occlusion and poor collaterals, p Values reported are expressed according to the following 
approximation, e.g: p < 0.02 ~ 0.01 < p < 0.02. 
lution to the anteroseptal wall was poor, but digital- 
subtracted images showed a clear subendocardial 
perfusion (Fig. 2, lower panel). Postoperative systolic 
function after weaning from cardiopulmonary by- 
pass was lower in this subgroup (PSWT from 9.0% 
_+ 8.5% to 16..3% _+ 7.4%;p < 0.08) when compared 
with that in the other subgroups with good collater- 
als or no LAD occlusion (Table V). 
No patients had new Q waves and pathologic 
release of creatine kinase MB after the operation. 
Discussion 
The goal of the cardioprotective approach during 
cardiac operations is to avoid myocardial stunning 
or necrosis; however, the ideal approach as not yet 
been established. Current data suggest hat ante- 
grade cardioplegia, in the presence of severe coro- 
nary artery stenosis or occlusion, may result in 
"unintentional myocardial ischemia" because of 
nonhomogeneous myocardial perfusion and cool- 
ing. ls-2° Retrograde cardioplegia can be used as an 
alternative, but more critical information on the 
pathophysiologic processes of retrograde perfusion 
is needed, 2°' 25 and the right atrial approach cannot 
be used in patients with either atrial septal defect or 
patent foramen ovale. 15 
Myocardial flow in the arrested heart differs from 
that in the beating heart and may not be anticipated 
by preoperative perfusion imaging techniques. For 
this reason MCE may play a central role in intraop- 
erative myocardial protection protocols because it 
allows detection of myocardial regions susceptible 
to inadequate perfusion. 4'6, 8, 11-15, 17 Quantitative 
MCE can be successfully used to identify myocardial 
regions that are receiving the least amount of car- 
dioplegic solution, and several parameters derived 
from time-intensity curves may be used to study 
regional myocardial f ow. 4' 13, 14 This method allows 
(1) detection of myocardial regions that escape the 
ischemic insult4; (2) improvement of the identifica- 
tion of collateral flow in comparison with coronary 
angiographyS, 6; and (3) evaluation of transmural 
blood flow distribution. 4 
The question related to the adequacy of collateral 
flow in the prevention of ischemia of the collateral- 
ized myocardium is still unanswered. 4' 5, s Coronary 
collaterals differ in terms 0f anatomy and flow 
pattern from the normal arterial vessels because 
they are characterized by marked endothelial cell 
proliferation and subintimal hyperplasia. 26'27 On 
the other hand, it has been demonstrated by tem- 
perature probes that good collateral circulation in 
patients with chronic, stable angina provides homo- 
geneous myocardial cooling that is independent of 
the route chosen for infusion of cardioplegic solu- 
tion.4, s However, this monitoring technique may be 
inadequate 28 and is useless when normothermic 
cardioplegia is used. In addition, data on the pro- 
tective role of poor Collaterals are lacking. 
The results of the present study confirm the role of 
intraoperative MCE in the assessment of regional 
myocardial f ow and the importance of collateral flow 
in protecting areas fed by an obstructed major coro- 
nary vessel. Parameters related to contrast wash-in 
(time to peak and ascending slope of the curve) and 
contrast wash-out (descending slope of the curve) 
were significantly different between patients with LAD 
stenosis and patients with LAD occlusion (Tables III 
and IV). This finding confirms that during cardiople- 
gia-induced maximal vasodilation collateral circulation 
represents a resistance to flow that is functionally 
comparable to a significant stenosis of a native coro- 
nary artery. 9' 10,29 Blood volume parameters (area 
under the time-intensity curve and peak of the curve) 
were not statistically different in the subgroups with 
LAD stenosis and occlusion when good collaterals 
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were present (Table IV, good collaterals column). In 
patients with LAD occlusion the whole area under the 
curve was not significantly affected by the presence of 
collateral circulation as shown by preoperative coro- 
nary arteriography (Fig. 1; Table IV, LAD occlusion 
column). However, when poor collaterals were consid- 
ered as a grouping factor, perfusion parameters were 
significantly lower in patients with LAD occlusion in 
the absence of postoperative electrocardiographic and 
enzymatic evidence of myocardial infarction. In accor- 
dance with the guidelines of the American Society of 
Anesthesiologists, 3° perioperative chocardiography 
may allow detection of poorly protected myocardial 
segments hat have an increased risk of "unintentional 
perioperative myocardial ischemia." 
Limitations. The limitations of this study are 
related to the following factors. 
Contrast agent. Different batches of sonicated al- 
bumin may have different concentrations and size 
distributions, which may significantly affect ultra- 
sonographic reflection. Peak contrast and area un- 
der the curve are more affected than contrast 
wash-in and wash-out parameters. Coulter or laser 
counting (Coulter Electronics, Hialeah, Fla.), mi- 
croscopic analysis, and ultrasonic characterization 
may be used to determine bubble size and concen- 
tration; however, these methods are not free from 
limitations. Microscopic evaluation, although time 
consuming, is an acceptable method for this purpose 
and may be used to unequivocally exclude the 
presence of large bubbles. 
Injection technique. Sonicated albumin micro- 
bubbles may be unstable under pressure and may 
collapse or be destroyed uring manual injection. In 
addition, both the speed of contrast injection and 
infusion of cardioplegic solution may not be constant. 
Imaging modality. Myocardial reflectivity may 
vary with changes in heart position. In addition, at 
low contrast concentration, myocardial perfusion 
may be underestimated because of the threshold 
effect; similarly, at high contrast concentration com- 
pression and attenuation of the signal by the com- 
mercially available ultrasonographic system may re- 
sult in perfusion underestimation. 
MCE is more sensitive than coronary arteriogra- 
phy in detecting perfusion of the collateralized 
myocardium5-7; thus the assignment of patients to 
groups with "good" and "poor" collaterals on the 
basis of coronary angiography may be misleading. 
Conclusions. We conclude that intraoperative 
MCE allows the assessment ofmyocardial perfusion 
in the cardioplegia-arrested heart when a complete 
analysis of all the time-intensity curve variables is 
done. 
Infusion of cardioplegic solution through the aortic 
root provides adequate myocardial perfusion in the 
presence of well-developed collateral circulation. Poor 
collateral circulation is characterized by a high resis- 
tance to flow and in this clinical setting coronary 
angiography may not predict he intraoperative p rfu- 
sion pattern. In the subset of patients with LAD 
occlusion and poor collaterals, antegrade cardioplegia 
may not provide complete myocardial protection, and 
alternative protective techniques may be used to avoid 
"unintentional myocardial ischemia," perioperative 
myocardial necrosis, or myocardial stunning. 
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Appendix 
The following notations are used herein: 
x i = acquisition time (i = 0, 1, 2, . . . ,  k, . . . ,  14, which 
correspond to xi = 0 second, 0.5 second, 1 second, 
. . . .  k/2 seconds . . . . .  7 seconds) 
2 = mean of x i values 
Yi = background-subtracted intensity value at time x i 
= mean of yi values 
k = index of the last measure within each time interval (k 
= 2, 4 , . . . ,  14 for area at 1 second, area at 2 seconds, 
. . . .  area at 7 seconds, respectively) 
k* = index of the time to peak and of the peak height 
Peak height and time to peak of the curve were defined as 
follows: 
14 
Peak height = y* = max (Yi) 
Time to peak = x* = acquisition time of the first usable y* 
The other parameters of the curve were calculated from 
the following formulas: 
k-1  
Areas under the curve = ~ (X i + 1 Xi) (Yi + Yi ÷ 1)/2 
i=0  
Area at peak = 
k* -  / 
E 
i=0  
(Xi  + 1 - -  X i )  (Yi -- Yi -~ 1)/2 
k* k s 
Ascending slope = ~ (xi - 2) (Yi - .9) /~ (xi - 2) 2 
i=0  i=0 
Descending slope = 
14 14 
(x~- ~) (y~- .9)/~ (xi- x) 2 
i = k* i = k* 
*Peak values. 
